Abstract | OBJECTIVE: We have previously shown that expression of the Bcl-3 gene, a member of the IκB family, is down-regulated in CD4+ T cells from patients with rheumatoid arthritis (RA) following tocilizumab therapy. The objective of this study was to examine the role of Bcl-3 in the pathogenesis of RA. METHODS:
DNA microarray analysis was used to compare the signal intensity of Bcl-3 in CD4+ T cells from untreated RA patients and healthy controls. We examined the roles of interleukin-6 (IL-6)/STAT-3 signaling in the induction of Bcl-3. In addition, we analyzed the gene expression profiles of Bcl-3-transduced CD4+ T cells by RNA sequencing. The effects of enforced expression as well as gene silencing of Bcl-3 on the development of follicular helper T (Tfh) cells were evaluated. Finally, we examined correlations between the signal intensities of Bcl-3 and Tfh cell-related genes in CD4+ T cells from untreated RA patients. RESULTS: Bcl-3 levels were significantly higher in RA patients than in healthy controls. IL-6 induced Bcl-3 expression in CD4+ T cells in a STAT-3-dependent manner. Transcriptome analysis revealed that the expression of Bcl-6, a master regulator of Tfh cell differentiation, was significantly up-regulated by the enforced Bcl-3 expression. The enforced Bcl-3 expression increased, but Bcl-3 silencing decreased, the numbers of IL-21-producing Tfh-like cells. Bcl-3 levels in CD4+ T cells from RA patients correlated positively with the levels of Tfh cell-related genes CXCR5, inducible costimulator, and achaete-scute homolog 2. CONCLUSION: Bcl-3 is involved in the development of Tfh cells and the pathogenesis of RA, presumably by inducing IL-21 production.
|
Authors | Kazuyuki Meguro, Kotaro Suzuki, Junichi Hosokawa, Yoshie Sanayama, Shigeru Tanaka, Shunsuke Furuta, Kei Ikeda, Hiroaki Takatori, Akira Suto, Akemi Sakamoto, Osamu Ohara, Hiroshi Nakajima |
Journal | Arthritis & rheumatology (Hoboken, N.J.)
(Arthritis Rheumatol)
Vol. 67
Issue 10
Pg. 2651-60
(Oct 2015)
ISSN: 2326-5205 [Electronic] United States |
PMID | 26138292
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015, American College of Rheumatology. |
Chemical References |
- B-Cell Lymphoma 3 Protein
- BCL3 protein, human
- Bcl3 protein, mouse
- Interleukin-6
- Interleukins
- Proto-Oncogene Proteins
- STAT3 Transcription Factor
- STAT3 protein, human
- Transcription Factors
- interleukin-21
|
Topics |
- Animals
- Arthritis, Rheumatoid
(pathology, physiopathology)
- B-Cell Lymphoma 3 Protein
- Case-Control Studies
- Cells, Cultured
- Humans
- Interleukin-6
(pharmacology, physiology)
- Interleukins
(physiology)
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Oligonucleotide Array Sequence Analysis
- Proto-Oncogene Proteins
(physiology)
- STAT3 Transcription Factor
(deficiency, genetics, physiology)
- Signal Transduction
(physiology)
- T-Lymphocytes, Helper-Inducer
(drug effects, pathology, physiology)
- Transcription Factors
(physiology)
|